Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BridgeBio Pharma (BBIO) Tax Rate (2024 - 2025)

BridgeBio Pharma (BBIO) has disclosed Tax Rate for 2 consecutive years, with 0.06% as the latest value for Q4 2025.

  • Quarterly Tax Rate rose 49.0% to 0.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.23% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.06% for FY2025, 15.0% up from the prior year.
  • Tax Rate hit 0.06% in Q4 2025 for BridgeBio Pharma, down from 0.8% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.8% in Q3 2025 to a low of 1.16% in Q2 2025.